{"data":{"id":"us/21-cfr-520.2700","jurisdiction":"us","citation":"21 CFR 520.2700","heading":"Verdinexor tablets.","body":"(a) Specifications. Each tablet contains 2.5, 10, 22.5, or 50 milligrams (mg) verdinexor.\n(b) Sponsor. See No. 043264 in § 510.600(c) of this chapter.\n(c) Conditions of use—(1) Amount. Administer verdinexor tablets orally at an initial dose of 1.25 mg per kilogram (mg/kg) of body weight twice per week with at least 72 hours between doses. If tolerated after 2 weeks, increase the dose to 1.5 mg/kg twice per week with at least 72 hours between doses.\n(2) Indications for use. For the treatment of lymphoma in dogs.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"8f0781b4324ad15080b4d8f27841dc65e747857ad99201bef8e9c5baf3073e61","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-520.2654","next":"us/21-cfr-522.23"},"notice":"GroundRules: Original legal text. Not legal advice."}